All Articles About Health Care
We found 37 entries; most recently published at the top.
Blog: In the Era of PRISM, ‘Knowing and Showing’ on Human Rights
Aditi Mohapatra, Associate Director, Advisory Services Dunstan Allison Hope, Managing Director, Advisory Services
As public scrutiny of U.S. government surveillance tactics grows, BSR has been reflecting on the corporate responsibility and ethics issues at stake—and how these issues extend beyond the information and communications technology sector. Read more →
Blog: Women’s World Banking: What Women’s Empowerment Means to Me
Mary Ellen Iskenderian, President and CEO, Women’s World Banking
In a guest blog, we hear from Women's World Banking on how public-private partnerships, in-depth market research, and financial products designed for the specific needs of women can contribute to women's empowerment. Read more →
BSR Insight Article: Improving Partnerships to Solve Global Health Challenges
Mark Little, Director, Healthcare, Advisory Services
BSR's new report on global health partnerships—an evaluation of 220 programs in more than 160 countries—reveals the challenges and success factors in partnerships between the pharmaceutical industry and NGOs, governments, and academia. Read more
Report: Working Toward Transformational Health Partnerships in Low- and Middle-Income Countries
Mark Little, Director, Healthcare, Advisory Services; Jennifer Schappert, Manager, Partnership Development
Global health partnerships play a key role in meeting many of the most critical health needs of low- and middle-income countries. This report summarizes the contribution of these partnerships to meeting global health needs and how to increase their scale and impact going forward. Read more
BSR Insight Article: Why Health Care Needs a New Business Model
Mark Little, Director, Healthcare, Advisory Services
For years, stakeholders have pressured health care companies to expand access to their products and services and do more to support global health goals, particularly in low- and middle-income countries. Some critics have fingered patents, or state-granted intellectual property rights, as the culprit. While companies consider patents their reward for taking significant investment risks in research and development, critics question whether the companies are truly committed to serving the broader public—or just trying to protect profits as long as they can. These are not new issues. Lately, however, even the critics have acknowledged that health care companies are finding profitable ways to address the world's health needs—at least when it comes to noncommunicable diseases like cardiovascular disease, diabetes, and cancer, which are among the world's biggest health concerns. China, for instance, has the world's highest incidence of diabetes—with a prevalence rate in children four times higher than in the United States—and, at the same time, the country has experienced a remarkable rise in living standards. The bottom line: While income growth fuels obesity and associated health burdens, it also means the Chinese market can pay for treatment. Unfortunately, this win-win is not the case for certain types of diseases, or for certain markets. And while it is not the primary responsibility of industry to ensure access to health (that is the role of government), it is evident that the industry's predominant business model could be further adapted to meet five key access challenges affecting low- and middle- income countries. Declining margins brought by pricing pressures, patent expiries, and costly R&D cycles are forcing health care companies to explore growth opportunities in non-Western markets. But given the outstanding challenges (below), it's time for the industry to ask itself: Is our business model broken? Read more
More Health Care Articles
Filter Health Care
- 6 Blog Entries
- 21 BSR Insight articles
- No BSR Voices podcasts at this time
- 3 Reports
- 2 Case Studies
- No Sustainable Investment in China articles at this time
